Aquestive Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2017 to Q2 2024.
  • Aquestive Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $2.78M, a 102% increase year-over-year.
  • Aquestive Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9.09M, a 48.9% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2023 was $6.34M, a 3.28% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2022 was $6.55M, a 34.8% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2021 was $10M, a 9.17% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.09M $2.78M +$1.41M +102% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.69M $2.78M +$1.35M +94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.34M $2.27M +$623K +37.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $5.71M $1.26M -$393K -23.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $6.11M $1.37M -$262K -16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $6.37M $1.44M -$183K -11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $6.55M $1.65M -$94K -5.39% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $6.65M $1.65M -$1.14M -40.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $7.78M $1.64M -$1.12M -40.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $8.91M $1.62M -$1.14M -41.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $10M $1.74M -$1.02M -37% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $11.1M $2.79M +$9K +0.32% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $11.1M $2.76M +$10K +0.36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $11.1M $2.76M -$10K -0.36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $11.1M $2.77M -$35K -1.25% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $11.1M $2.78M +$126K +4.75% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $11M $2.75M +$810K +41.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $10.2M $2.77M +$845K +43.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $9.32M $2.8M +$879K +45.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $8.44M $2.65M +$719K +37.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $7.72M $1.94M +$10K +0.52% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $7.71M $1.93M -$1K -0.05% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $7.71M $1.92M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 $1.93M -$37K -1.88% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $1.93M -$22K -1.13% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.93M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 $1.97M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $1.95M Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.